Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Therapeutic Drug Monitoring|September 26, 2003
Determination of thiopurine methyltransferase phenotype in isolated human erythrocytes using a new simple nonradioactive HPLC methodDessislava Indjova, Maria Shipkova, Srebrena Atanasova, et al.
Therapeutic Drug Monitoring|January 1, 2010
Mycophenolic acid predose concentrations and renal function in a mouse model for progressive renal fibrosisGunnar Brandhorst, Franziska Brehmer, Darinka T Petrova, et al.
Clinical Biochemistry|February 20, 2004
Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumoniaAnton A Igonin, Victor W Armstrong, Maria Shipkova, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|May 27, 2011
Differential kidney proteome profiling in a murine model of renal fibrosis under treatment with mycophenolate mofetilDarinka T Petrova, Franziska Brehmer, Frank C Schultze, et al.
Cell Biochemistry and Function|October 10, 2015
Mycophenolic acid reverses TGF beta-induced cell motility, collagen matrix contraction and cell morphology in vitroDarinka Todorova Petrova, Gunnar Brandhorst, Christian Koch, et al.
Critical Reviews in Clinical Laboratory Sciences|April 11, 2017
Using circulating cell-free DNA to monitor personalized cancer therapyMichael Oellerich, Ekkehard Schütz, Julia Beck, et al.
Therapeutic Drug Monitoring|January 24, 2014
Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantationMichael Oellerich, Ekkehard Schütz, Philipp Kanzow, et al.
Therapeutic Drug Monitoring|February 17, 2007
Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6Srebrena Atanasova, Maria Shipkova, Dobrin Svinarov, et al.
Clinical Pharmacology and Therapeutics|November 23, 2006
Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipientsMaarten Naesens, Dirk R J Kuypers, Frank Streit, et al.
Pageof 15